Revolution Medicines, Inc.
Anthony Mancini (See Remarks) sells RVMD shares
AI-generated summary
Anthony Mancini, See Remarks, exercised or converted derivatives for 811 shares of Common Stock for a total value of $27,334.22 at an average price of $33.70. Anthony Mancini also sold 811 shares of Common Stock for a total value of $162,200 at an average price of $200.00. Following these transactions, Anthony Mancini directly held 39,765 shares of Common Stock. The trades were made under a Rule 10b5-1 trading plan adopted on June 11, 2026.
Key facts
- Insider
- Anthony Mancini · See Remarks
Rule 10b5-1 plan · adopted Jun 11, 2026
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +810 | $33.62 | $27,232.20 | 40,575 | Direct |
| Nov 9, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +1 | $102.02 | $102.02 | 40,576 | Direct |
| Nov 9, 2026 | S · open-market saleFootnotes F1, F2 | −811 | $200.00 | $162,200.00 | 39,765 | Direct |
| Nov 9, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F1, F3 | −810 | $0.00 | $0.00 | 90,505 | Direct |
| Nov 9, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F1, F4 | −1 | $0.00 | $0.00 | 26,199 | Direct |
Footnotes
- F1 Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026.
- F2 Includes 39,575 restricted stock units.
- F3 Twenty-five percent of the total shares subject to the option will vest on the first year anniversary measured from April 1, 2025 (the "Vesting Commencement Date") and one forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary of the Vesting Commencement Date thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
- F4 One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2026 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
Remarks: Chief Global Commercialization Officer
More RVMD filings
- 144
Filed Nov 12, 2026
- SC 13G/A
Filed Nov 5, 2026
- 10-Q
Filed Nov 4, 2026
- 8-K
Filed Nov 4, 2026
- SC 13G
Filed Oct 30, 2026
- 4
Filed Oct 28, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.